1. Home
  2. DQ vs ATRC Comparison

DQ vs ATRC Comparison

Compare DQ & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DAQO New Energy Corp.

DQ

DAQO New Energy Corp.

HOLD

Current Price

$21.96

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

Logo AtriCure Inc.

ATRC

AtriCure Inc.

HOLD

Current Price

$29.54

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DQ
ATRC
Founded
2006
2000
Country
China
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
2010
2005

Fundamental Metrics

Financial Performance
Metric
DQ
ATRC
Price
$21.96
$29.54
Analyst Decision
Buy
Strong Buy
Analyst Count
4
7
Target Price
$28.91
$51.17
AVG Volume (30 Days)
493.7K
498.4K
Earning Date
04-29-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
74.74
EPS
N/A
N/A
Revenue
N/A
$201,630,000.00
Revenue This Year
$70.87
$15.27
Revenue Next Year
$34.92
$12.21
P/E Ratio
N/A
N/A
Revenue Growth
N/A
15.40
52 Week Low
$12.41
$27.26
52 Week High
$36.59
$43.18

Technical Indicators

Market Signals
Indicator
DQ
ATRC
Relative Strength Index (RSI) 51.28 50.68
Support Level $20.39 $28.26
Resistance Level $25.90 $30.75
Average True Range (ATR) 0.80 1.14
MACD 0.20 0.25
Stochastic Oscillator 83.87 67.10

Price Performance

Historical Comparison
DQ
ATRC

About DQ DAQO New Energy Corp.

Daqo New Energy Corp is a polysilicon manufacturer based in China. The company manufactures and sells high-purity polysilicon to manufacturers who use it to make ingots, cells, and modules for solar power solutions. The polysilicon is packaged to meet crucible stacking, pulling, and solidification needs. All of the company's revenues come from the People's Republic of China.

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Share on Social Networks: